Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyronaridine-artesunate for uncomplicated falciparum malaria in Viet Nam
ACTRN12618001274268Phase 4Completed
- Sponsor
- Vietnam Ministry of Health
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pyronaridine in malaria and Malaria, sponsored by Vietnam Ministry of Health. Primary endpoint: Day 42 PCR-corrected adequate clinical and parasitological response. Started May 2017; status: completed.
02
Drugs
pyronaridine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on ACTRN12618001274268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001274268.